Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug
Clinical trial NCT00819091 · COMPLETED
Trial details
- NCT number
- NCT00819091
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.